Department of Stomatology, First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, Zhejiang, 310006, China.
Department of Biobased Materials Science, Kyoto Institute of Technology, Sakyoku, Kyoto, 606-8585, Japan.
J Mech Behav Biomed Mater. 2022 Aug;132:105277. doi: 10.1016/j.jmbbm.2022.105277. Epub 2022 May 20.
An in-house built hybrid manufacturing device, combining the pros of melt electrowriting (MEW) and melt electrospinning (MES), is firstly proposed to produce a reinforced nonwoven fabric applied in drug delivery systems. MEW is used to print regular PCL lattice, followed by the deposition of a PCL nonwoven fabric loaded with drugs, forming a MEW/MES composite scaffold. Tensile test results suggest that after combining with MEW lattice, the strength of the composite scaffold can have a two-fold improvement and the elongation to break can increase up to 900%. Solvent vapor annealing is applied to adjust drug release rate through controlling the crystallinity of PCL. Although the increased crystallinity restrained drug release, a shish-kebab-shaped fiber structure formed by the annealing facilitates drug release. This MEW-based hybrid printing method can greatly enhance the freedom of making complex scaffold and extend to other nanotechnologies to fabricate reinforced scaffold as well.
一种内部构建的混合制造设备,结合了熔融静电纺丝(MES)和熔融电纺(MEW)的优点,首次被提出用于生产用于药物输送系统的增强型无纺纤维。MEW 用于打印规则的 PCL 格子,然后沉积负载有药物的 PCL 无纺纤维,形成 MEW/MES 复合支架。拉伸试验结果表明,与 MEW 格子结合后,复合支架的强度可提高一倍,断裂伸长率可提高到 900%。溶剂蒸气退火通过控制 PCL 的结晶度来调节药物释放速率。尽管结晶度的增加抑制了药物释放,但退火形成的 shish-kebab 纤维结构有利于药物释放。这种基于 MEW 的混合打印方法可以大大提高制造复杂支架的自由度,并扩展到其他纳米技术来制造增强型支架。